Page last updated: 2024-08-23

2-bromo-2'-deoxyadenosine and Leukemia, Myeloid, Acute

2-bromo-2'-deoxyadenosine has been researched along with Leukemia, Myeloid, Acute in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blakley, RL; Jamieson, GP; Lihou, MG; Pemble, LB; Smith, PJ	1

Other Studies

1 other study(ies) available for 2-bromo-2'-deoxyadenosine and Leukemia, Myeloid, Acute

Article	Year
Lack of cross-resistance between cytosine arabinoside and a new halogenated nucleoside analogue, 2-bromo-2'-deoxyadenosine in human acute myeloid leukaemia cells. Cancer chemotherapy and pharmacology, 1987, Volume: 20, Issue:2 Topics: Cell Line; Cytarabine; Cytidine Deaminase; Demecolcine; Deoxyadenosines; Deoxycytidine Kinase; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance; Flow Cytometry; Humans; Leukemia, Myeloid, Acute; Tumor Cells, Cultured; Tumor Stem Cell Assay	1987

Article

Year

Lack of cross-resistance between cytosine arabinoside and a new halogenated nucleoside analogue, 2-bromo-2'-deoxyadenosine in human acute myeloid leukaemia cells.

Cancer chemotherapy and pharmacology, 1987, Volume: 20, Issue:2

Topics: Cell Line; Cytarabine; Cytidine Deaminase; Demecolcine; Deoxyadenosines; Deoxycytidine Kinase; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance; Flow Cytometry; Humans; Leukemia, Myeloid, Acute; Tumor Cells, Cultured; Tumor Stem Cell Assay

1987